Get started
Author

Nobumi Miyake

Observed names: Miyake Nobumi, N Miyake, N. Miyake, NOBUMI MIYAKE
ORCID: 0000-0001-8694-5643
Observed ORCID: 0000-0001-8694-5643
OpenAlex ID: A5064499343
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
2012 · S Miyamoto, N Miyake, et al. · Molecular Psychiatry · 587
Benefits and limits of anticholinergic use in schizophrenia: Focusing on its effect on cognitive function
2013 · Shin Ogino, Seiya Miyamoto, et al. · Psychiatry and Clinical Neurosciences · 113
PDF
Imaging Changes in Glutamate Transmission In Vivo with the Metabotropic Glutamate Receptor 5 Tracer [11C] ABP688 and N-Acetylcysteine Challenge
2011 · Nobumi Miyake, Mette Skinbjerg, et al. · Biological Psychiatry · 67
Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia
2010 · Shin Ogino, Seiya Miyamoto, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 61
Presynaptic Dopamine in Schizophrenia
2010 · Nobumi Miyake, Judy Thompson, et al. · CNS Neuroscience & Therapeutics · 58
PDF
In Vivo Binding of Antipsychotics to D3 and D2 Receptors: A PET Study in Baboons with [11C]-(+)-PHNO
2010 · Ragy R. Girgis, Nobumi Miyake, et al. · Neuropsychopharmacology · 46
PDF
N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
2020 · Taro Kishi, Nobumi Miyake, et al. · Psychopharmacology · 41
Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic
2011 · Rei Kitajima, Seiya Miyamoto, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 39
Effects of a conventional mood stabilizer alone or in combination with second‐generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta‐analysis of randomized, placebo‐controlled trials
2021 · Taro Kishi, Kenji Sakuma, et al. · Bipolar Disorders · 29
New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia: Are We Making Real Progress?
2012 · Nobumi Miyake, Seiya Miyamoto, et al. · Clinical Schizophrenia & Related Psychoses · 26
Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta‐analysis of double‐blind, randomized, placebo‐controlled trials with an enrichment design
2019 · Kazuto Oya, Kenji Sakuma, et al. · Neuropsychopharmacology Reports · 21
PDF
Retracted: Effect of blonanserin on cognitive function in antipsychotic‐naïve first‐episode schizophrenia
2012 · Tomomi Tenjin, Seiya Miyamoto, et al. · Human Psychopharmacology Clinical and Experimental · 18
Barriers to long‐acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey
2024 · Yoshiyo Oguchi, Nobumi Miyake, et al. · Neuropsychopharmacology Reports · 17
PDF
Effects of N-Acetylcysteine on Cognitive Functions in Subjects With an At-Risk Mental State: A Case Series
2015 · Nobumi Miyake, Seiya Miyamoto, et al. · Journal of Clinical Psychopharmacology · 13
Retracted: Long‐term efficacy and safety of blonanserin in patients with first‐episode schizophrenia: A 1‐year open‐label trial
2014 · Yuriko Ninomiya, Seiya Miyamoto, et al. · Psychiatry and Clinical Neurosciences · 10
PDF
Successful treatment of delusional disorder with low‐dose aripiprazole
2008 · Seiya Miyamoto, Nobumi Miyake, et al. · Psychiatry and Clinical Neurosciences · 8
Recurrence of Mania or Depression Among Adult Bipolar Patients Who Continued Using Lithium: A Single-group Summary Meta-analysis of Randomized Trials
2020 · Taro Kishi, Kenji Sakuma, et al. · Journal of Clinical Psychopharmacology · 7
Safety profile of antidepressant for Japanese adults with major depressive disorder: A systematic review and network meta‐analysis
2023 · Taro Kishi, Toshikazu Ikuta, et al. · Psychiatry and Clinical Neurosciences · 6
PDF
[Effectiveness of N-acetylcysteine in the treatment of schizophrenia].
2016 · Nobumi Miyake, Seiya Miyamoto · PubMed · 4
Long‐acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID ‐19 pandemic: A micro‐narrative review
2024 · Yoshiyo Oguchi, Nobumi Miyake, et al. · Neuropsychopharmacology Reports · 3
PDF
Maintenance treatment for schizophrenia during the COVID-19 pandemic: the views of Japanese psychiatrists
2021 · Yoshiyo Oguchi, Nobumi Miyake, et al. · Clinical Neuropsychopharmacology and Therapeutics · 2
PDF
Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia
2007 · SEIYA MIYAMOTO, NOBUMI MIYAKE, et al. · Psychiatry and Clinical Neurosciences · 2
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
2026 · Nobumi Miyake, Toshiaki Haga, et al. · Neuropsychopharmacology Reports · 1
Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta‐analysis
2023 · Taro Kishi, Kenji Sakuma, et al. · Neuropsychopharmacology Reports · 1
Retraction: ‘Effect of blonanserin on cognitive function in antipsychotic‐naïve first‐episode schizophrenia’
2017 · Tomomi Tenjin, Seiya Miyamoto, et al. · Human Psychopharmacology Clinical and Experimental · 1
PDF
Works count: 39
Citation count: 1,182
H-index: 13
I10-index: 15
Year
Topic
Type